Juliane M Hartz1, David Engelmann2, Katharina Fürst1, Stephan Marquardt1, Alf Spitschak1, Deborah Goody1, Chris Protzel1, Oliver W Hakenberg1, Brigitte M Pützer1. 1. Institute of Experimental Gene Therapy and Cancer Research (JMH, DE, KF, SM, AS, DG, BMP), Rostock, Germany; Department of Urology, Rostock University Medical Center, Rostock, Germany. 2. Institute of Experimental Gene Therapy and Cancer Research (JMH, DE, KF, SM, AS, DG, BMP), Rostock, Germany; Department of Urology, Rostock University Medical Center, Rostock, Germany. Electronic address: david.engelmann@med.uni-rostock.de.
Abstract
PURPOSE: Penile squamous cell carcinoma is a rare but aggressive cancer. Little is known about pivotal events in tumor pathogenesis and metastasis. Lymph node metastasis is the prevailing prognostic factor while clinical detection in patients remains difficult. Our aim was to identify distinct miRNAs that are differentially expressed in metastatic vs nonmetastatic penile carcinoma, which may serve as diagnostic biomarkers for disease progression. MATERIALS AND METHODS: TaqMan® arrays and quantitative polymerase chain reaction were applied to analyze miRNA profiles in penile squamous cell carcinoma specimens and glans tissue from 24 patients. The prognostic value of deregulated miRNAs was analyzed using the Kaplan-Meier method. The Spearman test was applied to determine a potential linkage between distinctive miRNAs in individual patients. RESULTS: Loss of miR-1 (p = 0.0048), miR-101 (p = 0.0001) and miR-204 (p = 0.0004) in metastasizing tumors and associated metastases (p = 0.0151, 0.0019 and 0.0003, respectively) distinguished patients with metastatic and nonmetastatic penile squamous cell carcinoma. These 3 miRNAs showed a coherent expression pattern. Consistently, patients with low levels of all 3 miRNAs had worse survival (p = 0.03). We identified a coordinately regulated miRNA target hub that is over expressed in penile squamous cell carcinoma and associated with lymphovascular invasion. CONCLUSIONS: Our results provide evidence of a novel multiple miRNA based signature associated with lymph node metastasis and unfavorable prognosis of penile squamous cell carcinoma. The integrated loss of miR-1, miR-101 and miR-204 may predict the formation of metastases in penile cancer at an early stage.
PURPOSE:Penile squamous cell carcinoma is a rare but aggressive cancer. Little is known about pivotal events in tumor pathogenesis and metastasis. Lymph node metastasis is the prevailing prognostic factor while clinical detection in patients remains difficult. Our aim was to identify distinct miRNAs that are differentially expressed in metastatic vs nonmetastatic penile carcinoma, which may serve as diagnostic biomarkers for disease progression. MATERIALS AND METHODS: TaqMan® arrays and quantitative polymerase chain reaction were applied to analyze miRNA profiles in penile squamous cell carcinoma specimens and glans tissue from 24 patients. The prognostic value of deregulated miRNAs was analyzed using the Kaplan-Meier method. The Spearman test was applied to determine a potential linkage between distinctive miRNAs in individual patients. RESULTS: Loss of miR-1 (p = 0.0048), miR-101 (p = 0.0001) and miR-204 (p = 0.0004) in metastasizing tumors and associated metastases (p = 0.0151, 0.0019 and 0.0003, respectively) distinguished patients with metastatic and nonmetastatic penile squamous cell carcinoma. These 3 miRNAs showed a coherent expression pattern. Consistently, patients with low levels of all 3 miRNAs had worse survival (p = 0.03). We identified a coordinately regulated miRNA target hub that is over expressed in penile squamous cell carcinoma and associated with lymphovascular invasion. CONCLUSIONS: Our results provide evidence of a novel multiple miRNA based signature associated with lymph node metastasis and unfavorable prognosis of penile squamous cell carcinoma. The integrated loss of miR-1, miR-101 and miR-204 may predict the formation of metastases in penile cancer at an early stage.
Authors: Jenilson da Silva; Carla Cutrim da Costa; Ingryd de Farias Ramos; Ana Carolina Laus; Luciane Sussuchi; Rui Manuel Reis; André Salim Khayat; Luciane Regina Cavalli; Silma Regina Pereira Journal: Front Genet Date: 2022-06-24 Impact factor: 4.772
Authors: Juan Chipollini; Sharon Chaing; Mounsif Azizi; Laura C Kidd; Patricia Kim; Philippe E Spiess Journal: Int J Mol Sci Date: 2017-08-16 Impact factor: 5.923
Authors: Hellen Kuasne; Mateus C Barros-Filho; Ariane Busso-Lopes; Fábio A Marchi; Maisa Pinheiro; Juan J M Muñoz; Cristovam Scapulatempo-Neto; Eliney F Faria; Gustavo C Guimarães; Ademar Lopes; José C S Trindade-Filho; Maria Aparecida C Domingues; Sandra A Drigo; Silvia R Rogatto Journal: Oncotarget Date: 2017-02-28
Authors: Jaqueline Diniz Pinho; Gyl Eanes Barros Silva; Antonio Augusto Lima Teixeira Júnior; Marta Regina de Castro Belfort; Juliana Melo Mendes; Isabela Wernerck da Cunha; Luciana Gonçalves Quintana; José de Ribamar Rodrigues Calixto; Leudivan Ribeiro Nogueira; Ronald Wagner Pereira Coelho; André Salim Khayat Journal: Asian Pac J Cancer Prev Date: 2020-02-01
Authors: Jaqueline Diniz Pinho; Gyl Eanes Barros Silva; Antonio Augusto Lima Teixeira Júnior; Marta Regina de Castro Belfort; Juliana Melo Macedo Mendes; José de Ribamar Rodrigues Calixto; Leudivan Ribeiro Nogueira; Rommel Rodriguez Burbano; André Salim Khayat Journal: Transl Androl Urol Date: 2021-05